Lymphatic metastasis of breast cancer cells is associated with differential gene expression profiles that predict cancer stem cell-like properties and the ability to survive, establish and grow in a foreign environment

International Journal of Oncology

Volumn 35, Issue 2, 2009, Pages 297-308

  Pandit, Terlika S ^a   Kennette, Wendy ^a   MacKenzie, Lisa ^a   Zhang, Guihua ^a   Al Katib, Waleed ^a   Andrews, Joseph ^a   Vantyghem, Sharon A ^a   Ormond, D George ^a   Allan, Alison L ^a   Rodenhiser, David I ^a   Chambers, Ann F ^a   Tuck, Alan B ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Breast cancer; Cancer stem cells; Foreign microenvironment; Gene expression; Lymphatic metastasis

Indexed keywords

BLOOD CLOTTING FACTOR 8; COLLAGEN TYPE 5; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIN D1; CYTOKERATIN 14; CYTOKERATIN 17; CYTOKERATIN 6; EARLY GROWTH RESPONSE FACTOR 1; FIBRONECTIN; FIBULIN; LIPOCORTIN 1; SOMATOMEDIN BINDING PROTEIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSGELIN; UVOMORULIN; CD24 ANTIGEN; CD24 PROTEIN, HUMAN; CD44 PROTEIN, HUMAN; HERMES ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER STEM CELL; CELL GROWTH; CELL SURVIVAL; CLONOGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BREAST TUMOR; CELL PROLIFERATION; FLOW CYTOMETRY; GENETICS; PATHOLOGY;

ANIMALS; ANTIGENS, CD24; ANTIGENS, CD44; BREAST NEOPLASMS; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; LYMPHATIC METASTASIS; MICE; NEOPLASTIC STEM CELLS;

EID: 69449102415     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000340     Document Type: Article

References (38)

1. McGuire WL: Prognostic factors for recurrence and survival in human breast cancer. Breast Cancer Res Treat 10: 5-9, 1987.
2. Carter CL, Allen C and Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63: 181-187, 1989.
3. Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH and Murphy GP: Management and survival of female breast cancer: Results of a national survey by the American College of Surgeons. Cancer 45: 2917-2924, 1980.
4. Nathanson SD: Insights into the mechanisms of lymph node metastasis. Cancer 98: 413-423, 2003.
5. Nathanson SD: Preclinical models of regional lymph node tumor metastasis. Cancer Treat Res 135: 129-156, 2007.
6. Eccles S, Paon L and Sleeman J: Lymphatic metastasis in breast cancer: importance and new insights into cellular and molecular mechanisms. Clin Exp Metastasis 24: 619-636, 2007.
7. Dowlatshahi K, Fan M, Snider HC and Habib FA: Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 80: 1188-1197, 1997.
8. Page DL, Anderson TJ and Carter BA: Minimal solid tumor involvement of regional and distant sites: When is a metastasis not a metastasis? Cancer 86: 2589-2592, 1999.
9. Rampaul RS, Miremadi A, Pinder SE, Lee A and Ellis IO: Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer. Breast Cancer Res 3: 113-116, 2001.
10. Hermanek P, Hutter RV, Sobin LH and Wittekind C: International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer 86: 2668-2673, 1999.
11. Querzoli P, Pedriali M, Rinaldi R, Lombardi AR, Biganzoli E, Boracchi P, Ferretti S, Frasson C, Zanella C, Ghisellini S, Ambrogi F, Antolini L, Piantelli M, Iacobelli S, Marubini E, Alberti S and Nenci I: Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients. Clin Cancer Res 12: 6696-6701, 2006.
12. Rutgers EJ: Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases. J Clin Oncol 26: 698-702, 2008.
13. Pantel K and Brakenhoff RH: Dissecting the metastatic cascade. Nat Rev Cancer 4: 448-456, 2004.
14. Ward PM and Weiss L: The relationship between lymphogenous and hematogenous metastasis in rats bearing the MT-100-TC mammary carcinoma. Clin Exp Metastasis 7: 253-264, 1989.
15. Ward PM and Weiss L: Metachronous seeding of lymph node metastases in rats bearing the MT-100-TC mammary carcinoma: the effect of elective lymph node dissection. Breast Cancer Res Treat 14: 315-320, 1989.
16. Tobler NE and Detmar M: Tumor and lymph node lymphangio-genesis - impact on cancer metastasis. J Leukoc Biol 80: 691-696, 2006.
17. Sleeman JP: The lymph node as a bridgehead in the metastatic dissemination of tumors. Recent Results Cancer Res 157: 55-81, 2000.
18. Vantyghem SA, Allan AL, Postenka CO, Al-Katib W, Keeney M, Tuck AB and Chambers AF: A new model for lymphatic metastasis: development of a variant of the MDA-MB-468 human breast cancer cell line that aggressively metastasizes to lymph nodes. Clin Exp Metastasis 22: 351-361, 2005.
19. Feng Y, Sun B, Li X, Zhang L, Niu Y, Xiao C, Ning L, Fang Z, Wang Y, Zhang L, Cheng J, Zhang W and Hao X: Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients. Breast Cancer Res Treat 103: 319-329, 2007.
20. Hao X, Sun B, Hu L, Lahdesmaki H, Dunmire V, Feng Y, Zhang SW, Wang H, Wu C, Wang H, Fuller GN, Symmans WF, Shmulevich I and Zhang W: Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer 100: 1110-1122, 2004.
21. Vecchi M, Confalonieri S, Nuciforo P, Vigano MA, Capra M, Bianchi M, Nicosia D, Bianchi F, Galimberti V, Viale G, Palermo G, Riccardi A, Campanini R, Diadone MG, Pierotti MA, Pece S and DiFiore PP: Breast cancer metastases are molecularly distinct from their primary tumors. Oncogene 27: 2148-2158, 2008.
22. Dalerba P and Clarke MF: Cancer stem cells and tumor metastasis: First steps into uncharted territory. Cell Stem Cell 1: 241-242, 2007.
23. Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, Halushka MK, Sukumar S, Parker LM, Anderson KS, Harris LN, Garber JE, Richardson AL, Schnitt SJ, Nikolsky Y, Gelman RS and Polyak K: Molecular definition of breast tumor heterogeneity. Cancer Cell 11: 259-273, 2007.
24. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988, 2003.
25. Shipitsin M and Polyak K: The cancer stem cell hypothesis: In search of definitions, markers, and relevance. Lab Invest 88: 459-463, 2008.
26. Cailleau R, Olive M and Cruciger QV: Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14: 911-915, 1978.
27. Glinsky GV, Berezovska O and Glinskii AB: Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 115: 1503-1521, 2005.
28. Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, Sherlock G, Lewicki J, Shedden K and Clarke MF: The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356: 217-226, 2007.
29. Polyak K and Hahn WC: Roots and stems: stem cells in cancer. Nat Med 12: 296-300, 2006.
30. - breast cancer cells exhibit enhanced invasive properties: An early step necessary for metastasis. Breast Cancer Res 8: R59, 2006.
31. Kaplan RN, Rafii S and Lyden D: Preparing the 'soil': the premetastatic niche. Cancer Res 66: 11089-11093, 2006.
32. Chambers AF, Groom AC and MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572, 2002.
33. Chang CC: Recent translational research: stem cells as the roots of breast cancer. Breast Cancer Res 8: 103, 2006.
34. Balic M, Lin H, Young L, Hawes D, Giuliano A, McNamara G, Datar RH and Cote RJ: Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 12: 5615-5621, 2006.
35. Ginestier C, Korkaya H, Dontu G, Birnbaum D, Wicha MS and Charafe-Jaufrette E: The cancer stem cell: the breast cancer driver. Med Sci (Paris) 23: 1133-1139, 2007.
36. + cells with cancer stem cell characteristics. Breast Cancer Res 10: R10, 2008.
37. Li L and Neaves WB: Normal stem cells and cancer stem cells: the niche matters. Cancer Res 66: 4553-4557, 2006.
38. Li F, Tiede B, Massague J and Kang Y: Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res 17: 3-14, 2007.